ANG Lifesciences India Limited (ANG.BO)
INR 27.9
(1.05%)
INR 27.9
(1.05%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.42 Billion INR | -13.32% |
| 2022 | 2.79 Billion INR | -3.89% |
| 2021 | 2.91 Billion INR | 102.6% |
| 2020 | 1.43 Billion INR | 52.7% |
| 2019 | 940.75 Million INR | 16.29% |
| 2018 | 808.97 Million INR | 18.68% |
| 2017 | 681.65 Million INR | 45.53% |
| 2016 | 468.38 Million INR | 31.96% |
| 2015 | 354.93 Million INR | 37.34% |
| 2014 | 258.44 Million INR | 2.64% |
| 2013 | 251.78 Million INR | 17.79% |
| 2012 | 213.75 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 2.42 Billion INR | 0.0% |
| 2023 Q2 | 2.69 Billion INR | 0.0% |
| 2023 FY | 2.42 Billion INR | -13.32% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 2.79 Billion INR | -3.89% |
| 2022 Q4 | 2.79 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 2.89 Billion INR | 0.0% |
| 2021 Q2 | 2.63 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 2.91 Billion INR | 0.0% |
| 2021 FY | 2.91 Billion INR | 102.6% |
| 2021 Q1 | - INR | -100.0% |
| 2020 FY | 1.43 Billion INR | 52.7% |
| 2020 Q4 | 1.43 Billion INR | 0.0% |
| 2020 Q1 | 1.1 Billion INR | 17.19% |
| 2020 Q2 | 1.1 Billion INR | 0.0% |
| 2019 Q1 | 846.89 Million INR | 4.69% |
| 2019 Q3 | 940.75 Million INR | 11.08% |
| 2019 Q4 | 940.75 Million INR | 0.0% |
| 2019 Q2 | 846.89 Million INR | 0.0% |
| 2019 FY | 940.75 Million INR | 16.29% |
| 2018 Q4 | 808.97 Million INR | 0.0% |
| 2018 FY | 808.97 Million INR | 18.68% |
| 2018 Q3 | 808.97 Million INR | 9.61% |
| 2018 Q2 | 738.01 Million INR | 0.0% |
| 2018 Q1 | 738.01 Million INR | 8.27% |
| 2017 Q1 | 506.59 Million INR | 8.16% |
| 2017 Q2 | 506.59 Million INR | 0.0% |
| 2017 Q3 | 681.65 Million INR | 34.55% |
| 2017 Q4 | 681.65 Million INR | 0.0% |
| 2017 FY | 681.65 Million INR | 45.53% |
| 2016 FY | 468.38 Million INR | 31.96% |
| 2016 Q3 | 468.38 Million INR | 20.01% |
| 2016 Q2 | 390.28 Million INR | 0.0% |
| 2016 Q1 | 390.28 Million INR | 0.0% |
| 2016 Q4 | 468.38 Million INR | 0.0% |
| 2015 FY | 354.93 Million INR | 37.34% |
| 2014 FY | 258.44 Million INR | 2.64% |
| 2013 FY | 251.78 Million INR | 17.79% |
| 2012 FY | 213.75 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Bacil Pharma Limited | 13.26 Million INR | -18181.94% |
| BDH Industries Limited | 934.11 Million INR | -159.537% |
| Beryl Drugs Limited | 174.86 Million INR | -1286.391% |
| Cian Healthcare Limited | 1.61 Billion INR | -50.418% |
| Chemo Pharma Laboratories Limited | 130.15 Million INR | -1762.721% |
| Deccan Health Care Limited | 1.08 Billion INR | -124.379% |
| DECIPHER LABS LIMITED | 336.33 Million INR | -620.828% |
| Add-Shop E-Retail Limited | 1.25 Billion INR | -92.48% |
| Concord Drugs Limited | 588.06 Million INR | -312.263% |
| Gujarat Terce Laboratories Limited | 232.73 Million INR | -941.686% |
| Gujarat Themis Biosyn Limited | 2.21 Billion INR | -9.644% |
| Hindustan Bio Sciences Limited | 33.74 Million INR | -7084.802% |
| Ishita Drugs and Industries Limited | 108.08 Million INR | -2142.978% |
| Jenburkt Pharmaceuticals Limited | 1.65 Billion INR | -46.843% |
| KIMIA BIOSCIENCES LIMITED | 999.66 Million INR | -142.518% |
| Kwality Pharmaceuticals Limited | 3.94 Billion INR | 38.501% |
| Makers Laboratories Limited | 1.61 Billion INR | -50.343% |
| Medi-Caps Limited | 1.27 Billion INR | -90.468% |
| MedPlus Health Services Limited | 30.04 Billion INR | 91.932% |
| Panchsheel Organics Limited | 1.59 Billion INR | -52.424% |
| Parmax Pharma Limited | 176.12 Million INR | -1276.494% |
| Parnax Lab Limited | 1.88 Billion INR | -28.433% |
| Patidar Buildcon Limited | 94.27 Million INR | -2471.564% |
| Phaarmasia Limited | 314.47 Million INR | -670.918% |
| PRAVEG LIMITED | 3.64 Billion INR | 33.504% |
| Sunil Healthcare Limited | 1.58 Billion INR | -52.957% |
| Syschem (India) Limited | 1.64 Billion INR | -47.802% |
| Sanjivani Paranteral Limited. | 434.05 Million INR | -458.542% |
| Sastasundar Ventures Limited | 11.49 Billion INR | 78.911% |
| SHAMROCK INDUSTRIAL CO.LTD. | 17.6 Million INR | -13674.036% |
| Smruthi Organics Limited | 1.18 Billion INR | -105.123% |
| Source Natural Foods and Herbal Supplements Limited | 236.5 Million INR | -925.072% |
| SUDARSHAN PHARMA INDUSTRIES LI | 2.83 Billion INR | 14.371% |
| Trident Lifeline Limited | 870.76 Million INR | -178.419% |
| Transchem Limited | 763.18 Million INR | -217.667% |
| Trinity League India Limited | 32.38 Million INR | -7385.852% |
| Tyche Industries Limited | 1.36 Billion INR | -77.091% |
| Vikram Thermo (India) Limited | 1.42 Billion INR | -69.922% |
| Vista Pharmaceuticals Limited | 579.79 Million INR | -318.146% |
| Vivanza Biosciences Limited | 195.01 Million INR | -1143.176% |
| Zenith Healthcare Limited | 97.41 Million INR | -2388.752% |
| Zenlabs Ethica Limited | 402.58 Million INR | -502.202% |
| Mercury Laboratories Limited | 679.57 Million INR | -256.748% |
| SHELTER PHARMA LIMITED | 379.14 Million INR | -539.425% |
| Vasundhara Rasayans Limited | 373.03 Million INR | -549.912% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1.88 Billion INR | -28.513% |
| Roopa Industries Limited | 647.82 Million INR | -274.234% |
| PANJON LTD. | 173.91 Million INR | -1294.02% |
| Pharmaids Pharmaceuticals Limited | 913.4 Million INR | -165.42% |
| TIAAN CONSUMER LIMITED | 95.12 Million INR | -2448.64% |
| Anuh Pharma Limited | 4.45 Billion INR | 45.603% |
| Crestchem Limited | 71.44 Million INR | -3293.477% |
| Emmessar Biotech & Nutrition Limited | 87.42 Million INR | -2672.956% |
| Sandu Pharmaceuticals Limited | 524.14 Million INR | -362.534% |
| Fredun Pharmaceuticals Limited | 3.07 Billion INR | 21.184% |
| Trimurthi Limited | 73.64 Million INR | -3191.784% |
| Shukra Pharmaceuticals Limited | 778.37 Million INR | -211.467% |
| Norris Medicines Limited | 141.87 Million INR | -1608.829% |
| Veerhealth Care Limited | 281.16 Million INR | -762.249% |
| Lactose (India) Limited | 1 Billion INR | -140.659% |
| OXYGENTA PHARMACEUTICAL LIMITE | 631.92 Million INR | -283.65% |
| Ambalal Sarabhai Enterprises Limited | 2.5 Billion INR | 3.114% |
| Gennex Laboratories Limited | 2.29 Billion INR | -5.414% |
| Denis Chem Lab Limited | 1.09 Billion INR | -121.71% |
| Colinz Laboratories Limited | 113.59 Million INR | -2034.239% |
| Godavari Drugs Limited | 1.34 Billion INR | -79.913% |
| Zenotech Laboratories Limited | 1.06 Billion INR | -128.269% |
| Shree Ganesh Remedies Limited | 1.7 Billion INR | -41.83% |
| Bharat Parenterals Limited | 5.03 Billion INR | 51.881% |
| Coral Laboratories Limited | 2.05 Billion INR | -17.871% |
| Evoq Remedies Limited | 368.61 Million INR | -557.705% |
| Kerala Ayurveda Limited | 1.4 Billion INR | -72.067% |
| KOBO BIOTECH LIMITED | 713.93 Million INR | -239.578% |
| Natural Capsules Limited | 3.76 Billion INR | 35.612% |
| Auro Laboratories Limited | 852.67 Million INR | -184.324% |